Dr. Hönle AG

Informe acción XTRA:HNL

Capitalización de mercado: €120.3m

Dr. Hönle Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Dr. Hönle han disminuido a una tasa media anual de -70.5%, mientras que en la industria Electrical los beneficios crecieron en un 38.6% anualmente. Los ingresos han ido disminuyendo a una tasa media de 0.6% al año.

Información clave

-70.5%

Tasa de crecimiento de los beneficios

-70.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Electrical 30.3%
Tasa de crecimiento de los ingresos-0.6%
Rentabilidad financiera-14.7%
Margen neto-13.5%
Próxima actualización de resultados08 May 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

Feb 08
Dr. Hönle AG's (ETR:HNL) Popularity With Investors Is Clear

We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Oct 11
We Think Dr. Hönle (ETR:HNL) Has A Fair Chunk Of Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Aug 07
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 03
Is Dr. Hönle (ETR:HNL) A Risky Investment?

The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Nov 03
The Returns On Capital At Dr. Hönle (ETR:HNL) Don't Inspire Confidence

Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

Sep 29
Dr. Hönle (ETR:HNL) Has No Shortage Of Debt

There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Jul 06
There Are Reasons To Feel Uneasy About Dr. Hönle's (ETR:HNL) Returns On Capital

Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Feb 20
Capital Allocation Trends At Dr. Hönle (ETR:HNL) Aren't Ideal

Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Jul 15
Dr. Hönle AG (ETR:HNL) Shares Could Be 37% Below Their Intrinsic Value Estimate

Is Dr. Hönle (ETR:HNL) A Risky Investment?

Jun 14
Is Dr. Hönle (ETR:HNL) A Risky Investment?

Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

May 30
Is Dr. Hönle AG (ETR:HNL) Potentially Undervalued?

Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

May 17
Dr. Hönle (ETR:HNL) Could Be Struggling To Allocate Capital

Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Mar 29
Calculating The Fair Value Of Dr. Hönle AG (ETR:HNL)

Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

Mar 16
Do Investors Have Good Reason To Be Wary Of Dr. Hönle AG's (ETR:HNL) 1.0% Dividend Yield?

We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Mar 03
We Think Dr. Hönle (ETR:HNL) Is Taking Some Risk With Its Debt

Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

Feb 20
Is It Too Late To Consider Buying Dr. Hönle AG (ETR:HNL)?

We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Feb 08
We Wouldn't Rely On Dr. Hönle's (ETR:HNL) Statutory Earnings As A Guide

Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Jan 25
Did Business Growth Power Dr. Hönle's (ETR:HNL) Share Price Gain of 131%?

Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

Jan 11
Should We Be Excited About The Trends Of Returns At Dr. Hönle (ETR:HNL)?

What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dec 27
What Kind Of Investors Own Most Of Dr. Hönle AG (ETR:HNL)?

Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Dec 15
Dr. Hönle AG (ETR:HNL) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?

Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

Dec 03
Is Dr. Hönle AG (ETR:HNL) An Attractive Dividend Stock?

These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Nov 22
These 4 Measures Indicate That Dr. Hönle (ETR:HNL) Is Using Debt Extensively

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Dr. Hönle. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).


Historial de beneficios e ingresos

XTRA:HNL Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Dec 23103-14410
30 Sep 23106-11400
30 Jun 23109-10410
31 Mar 23109-1400
31 Dec 221131400
30 Sep 221163400
30 Jun 22118-3410
31 Mar 22118-3420
31 Dec 21119-3420
30 Sep 21115-5410
30 Jun 211076370
31 Mar 211016350
31 Dec 20955340
30 Sep 20946340
30 Jun 20988370
31 Mar 2010310370
31 Dec 1910310370
30 Sep 1910812370
30 Jun 1911917380
31 Mar 1912218390
31 Dec 1812721390
30 Sep 1812722380
30 Jun 1811919360
31 Mar 1811617350
31 Dec 1711014350
30 Sep 1710210340
30 Jun 17978340
31 Mar 17969340
31 Dec 16938330
30 Sep 16948330
30 Jun 16949320
31 Mar 16939320
31 Dec 159310310
30 Sep 159310310
30 Jun 15888300
31 Mar 15868300
31 Dec 14846290
30 Sep 14826290
30 Jun 14808290
31 Mar 14827290
31 Dec 13817280
30 Sep 13787270
30 Jun 13816270

Ingresos de calidad: HNL actualmente no es rentable.

Margen de beneficios creciente: HNL actualmente no es rentable.


Análisis del flujo de caja libre vs. Beneficios


Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: HNL no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 70.5% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de HNL en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: HNL no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Electrical (18.6%).


Rentabilidad financiera

Alta ROE: HNL tiene una rentabilidad financiera negativa (-14.66%), ya que actualmente no es rentable.


Rentabilidad económica


Rendimiento del capital invertido


Descubre empresas con buenos resultados en el pasado